KPTI20260417C15
KPTI Apr 17 2026 15.00 Call (KPTI260417C00015000)
option OPRA

karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com